Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin

Nature Medicine

Volumn 21, Issue 8, 2015, Pages 880-886

  Zenaro, Elena ^a   Pietronigro, Enrica ^a   Bianca, Vittorina Della ^a   Piacentino, Gennj ^a   Marongiu, Laura ^a   Budui, Simona ^a   Turano, Ermanna ^a   Rossi, Barbara ^a   Angiari, Stefano ^a   Dusi, Silvia ^a   Montresor, Alessio ^a   Carlucci, Tommaso ^a   Nanì, Sara ^a   Tosadori, Gabriele ^a   Calciano, Lucia ^a   Catalucci, Daniele ^a   Berton, Giorgio ^b   Bonetti, Bruno ^a   Constantin, Gabriela ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL MIGRATION; COGNITIVE DEFECT; CONTROLLED STUDY; EXTRACELLULAR TRAP; GLIOSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROPATHOLOGY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; COGNITION DISORDERS; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

MUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELL ADHESION; CELL MOVEMENT; COGNITION DISORDERS; EXTRACELLULAR TRAPS; HUMANS; INTERLEUKIN-17; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHILS; PEPTIDE FRAGMENTS;

EID: 84939000054     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3913     Document Type: Article

References (58)

1. Querfurth, H.W. & LaFerla, F.M. Alzheimers disease. N. Engl. J. Med. 362, 329-344 (2010).
2. Selkoe, D.J. Alzheimers disease is a synaptic failure. Science 298, 789-791 (2002).
3. Wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015 (2006).
4. Schwartz, M., Kipnis, J., Rivest, S. & Prat, A. How do immune cells support and shape the brain in health, disease, and aging? J. Neurosci. 33, 17587-17596 (2013).
5. Czirr, E. & Wyss-Coray, T. The immunology of neurodegeneration. J. Clin. Invest. 122, 1156-1163 (2012).
6. Krstic, D. & Knuesel, I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 9, 25-34 (2013).
7. Kitazawa, M., Oddo, S., Yamasaki, T.R., Green, K.N. & LaFerla, F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimers disease. J. Neurosci. 25, 8843-8853 (2005).
8. in t Veld, B.A. et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimers disease. N. Engl. J. Med. 345, 1515-1521 (2001).
9. Szekely, C.A. & Zandi, P.P. Non-steroidal anti-inflammatory drugs and Alzheimers disease: the epidemiological evidence. CNS Neurol. Disord. Drug Targets 9, 132-139 (2010).
10. Block, M.L., Zecca, L. & Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69 (2007).
11. Cagnin, A. et al. In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467 (2001).
12. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimers disease. Nat. Genet. 43, 429-435 (2011).
13. Lambert, J.C. et al. Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimers disease. Nat. Genet. 45, 1452-1458 (2013).
14. Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimers disease. N. Engl. J. Med. 368, 107-116 (2013).
15. Prokop, S., Miller, K.R. & Heppner, F.L. Microglia actions in Alzheimers disease. Acta Neuropathol. 126, 461-477 (2013).
16. Zlokovic, B.V. Neurovascular pathways to neurodegeneration in Alzheimers disease and other disorders. Nat. Rev. Neurosci. 12, 723-738 (2011).
17. Rossi, B., Angiari, S., Zenaro, E., Budui, S.L. & Constantin, G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J. Leukoc. Biol. 89, 539-556 (2011).
18. Savage, M.J. et al. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60, 607-619 (1994).
19. Togo, T. et al. Occurrence of T cells in the brain of Alzheimers disease and other neurological diseases. J. Neuroimmunol. 124, 83-92 (2002).
20. Subramanian, S. et al. CCR6: a biomarker for Alzheimers-like disease in a triple transgenic mouse model. J. Alzheimers Dis. 22, 619-629 (2010).
21. Baik, S.H. et al. Migration of neutrophils targeting amyloid plaques in Alzheimers disease mouse model. Neurobiol. Aging 35, 1286-1292 (2014).
22. Michaud, J.P., Bellavance, M.A., Préfontaine, P. & Rivest, S. Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Reports 5, 646-653 (2013).
23. Oakley, H. et al. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimers disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140 (2006).
24. Oddo, S. et al. Triple-transgenic model of Alzheimers disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409-421 (2003).
25. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B.P. & LaFerla, F.M. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimers disease. Neurobiol. Aging 24, 1063-1070 (2003).
26. Billings, L.M., Oddo, S., Green, K.N., McGaugh, J.L. & LaFerla, F.M. Intraneuronal Aβ causes the onset of early Alzheimers disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688 (2005).
27. Janelsins, M.C. et al. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimers disease mice. J. Neuroinflammation 2, 23 (2005).
28. Green, K.N., Billings, L.M., Roozendaal, B., McGaugh, J.L. & LaFerla, F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimers disease. J. Neurosci. 26, 9047-9056 (2006).
29. Mastrangelo, M.A. & Bowers, W.J. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimers disease-related pathologies in male triple-transgenic mice. BMC Neurosci. 9, 81 (2008).
30. Phillipson, M. & Kubes, P. The neutrophil in vascular inflammation. Nat. Med. 17, 1381-1390 (2011).
31. Kolaczkowska, E. & Kubes, P. P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol 13, 159-175 (2013).
32. Kebir, H. et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175 (2007).
33. Siffrin, V. et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424-436 (2010).
34. DiStasi, M.R. & Ley, K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 30, 547-556 (2009).
35. Bolton, S.J., Anthony, D.C. & Perry, V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 86, 1245-1257 (1998).
36. Kalaria, R.N. The blood-brain barrier and cerebrovascular pathology in Alzheimers disease. Ann. NY Acad. Sci. 893, 113-125 (1999).
37. Gautam, N., Herwald, H., Hedqvist, P. & Lindbom, L. Signaling via beta(2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. J. Exp. Med. 191, 1829-1839 (2000).
38. Ryu, J.K. & McLarnon, J.G. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimers disease brain. J. Cell. Mol. Med. 13, 2911-2925 (2009).
39. Ley, K., Laudanna, C., Cybulsky, M.I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689 (2007).
40. Silva, M.T. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol. 87, 805-813 (2010).
41. Soehnlein, O. & Lindbom, L. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10, 427-439 (2010).
42. Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625 (2009).
43. Garcia-Romo, G.S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011).
44. Allen, C. et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J. Immunol. 189, 381-392 (2012).
45. Baldwin, K.J. & Hogg, J.P. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis. Curr. Opin. Neurol. 26, 318-323 (2013).
46. Sterniczuk, R., Antle, M.C., Laferla, F.M. & Dyck, R.H. Characterization of the 3xTg-AD mouse model of Alzheimers disease: part 2. Behavioral and cognitive changes. Brain Res. 1348, 149-155 (2010).
47. Halagappa, V.K. et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimers disease. Neurobiol. Dis. 26, 212-220 (2007).
48. Nakashima, A.S., Oddo, S., Laferla, F.M. & Dyck, R.H. Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice. Neurobiol. Aging 31, 605-613 (2010).
49. Robertson, R.T. et al. Amyloid-beta expression in retrosplenial cortex of triple transgenic mice: relationship to cholinergic axonal afferents from medial septum. Neuroscience 164, 1334-1346 (2009).
50. España, J. et al. Intraneuronal β-Amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimers disease transgenic mice. Biol. Psychiatry 67, 513-521 (2010).
51. Kim, H.J. et al. Selective neuronal degeneration induced by soluble oligomeric amyloid beta-protein. FASEB J. 17, 118-120 (2003).
52. Bolomini-Vittori, M. et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat. Immunol. 10, 185-194 (2009).
53. Lundqvist, H. & Dahlgren, C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic. Biol. Med. (Paris) 20, 785-792 (1996).
54. Fumagalli, L. et al. Class I phosphoinositide-3-kinases and SRC kinases play a nonredundant role in regulation of adhesion-independent and -dependent neutrophil reactive oxygen species generation. J. Immunol. 190, 3648-3660 (2013).
55. Flister, M.J. et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-κB and Prox1. Blood 115, 418-429 (2010).
56. Kook, S.-Y. et al. Aβ1-42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling. J. Neurosci. 32, 8845-8854 (2012).
57. Ohira, K., Takeuchi, R., Iwanaga, T. & Miyakawa, T. Chronic fluoxetine treatment reduces parvalbumin expression and perineuronal nets in gamma-aminobutyric acidergic interneurons of the frontal cortex in adult mice. Mol. Brain 6, 43 (2013).
58. Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimers disease. J. Neurosci. 21, 372-381 (2001).